DK1709044T3 - Oxazolidinon-quinolon-hybridantibiotika - Google Patents

Oxazolidinon-quinolon-hybridantibiotika

Info

Publication number
DK1709044T3
DK1709044T3 DK04804099T DK04804099T DK1709044T3 DK 1709044 T3 DK1709044 T3 DK 1709044T3 DK 04804099 T DK04804099 T DK 04804099T DK 04804099 T DK04804099 T DK 04804099T DK 1709044 T3 DK1709044 T3 DK 1709044T3
Authority
DK
Denmark
Prior art keywords
oxazolidinone
quinolone hybrid
hybrid antibiotics
antibiotics
quinolone
Prior art date
Application number
DK04804099T
Other languages
English (en)
Other versions
DK1709044T4 (da
Inventor
Christian Hubschwerlen
J L Specklin
Daniel Kaspar Baeschlin
Christine Schmitt
Stefan Mueller
Michael Cappi
Original Assignee
Morphochem Ag Komb Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39109376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1709044(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP04001506A external-priority patent/EP1557416A1/en
Application filed by Morphochem Ag Komb Chemie filed Critical Morphochem Ag Komb Chemie
Application granted granted Critical
Publication of DK1709044T3 publication Critical patent/DK1709044T3/da
Publication of DK1709044T4 publication Critical patent/DK1709044T4/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4087Esters with arylalkanols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK04804099T 2003-12-18 2004-12-20 Oxazolidinon-quinolon-hybridantibiotika DK1709044T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53082203P 2003-12-18 2003-12-18
EP04001506A EP1557416A1 (en) 2004-01-23 2004-01-23 Oxazolidinone-quinolone hybrid antibiotics
PCT/EP2004/014500 WO2005058888A2 (en) 2003-12-18 2004-12-20 Oxazolidinone-quinolone hybrid antibiotics

Publications (2)

Publication Number Publication Date
DK1709044T3 true DK1709044T3 (da) 2008-11-03
DK1709044T4 DK1709044T4 (da) 2014-01-20

Family

ID=39109376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04804099T DK1709044T4 (da) 2003-12-18 2004-12-20 Oxazolidinon-quinolon-hybridantibiotika

Country Status (21)

Country Link
US (3) US8501774B2 (da)
EP (1) EP1709044B2 (da)
JP (2) JP2007516263A (da)
KR (1) KR101176450B1 (da)
CN (2) CN1898238A (da)
AT (1) ATE401326T1 (da)
AU (1) AU2004299278C9 (da)
BR (1) BRPI0417193B8 (da)
CA (1) CA2549675C (da)
CY (1) CY1108409T1 (da)
DE (1) DE602004015158D1 (da)
DK (1) DK1709044T4 (da)
ES (1) ES2310299T5 (da)
IL (1) IL175409A (da)
MX (1) MXPA06006769A (da)
NZ (1) NZ547382A (da)
PL (1) PL1709044T5 (da)
PT (1) PT1709044E (da)
RU (1) RU2371443C2 (da)
SI (1) SI1709044T2 (da)
WO (1) WO2005058888A2 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
ES2308171T3 (es) 2003-04-30 2008-12-01 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
AR054608A1 (es) * 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
EP2181994B1 (en) 2006-03-31 2014-05-28 Research Foundation Itsuu Laboratory Antimicrobial compounds
ATE544764T1 (de) * 2006-11-10 2012-02-15 Actelion Pharmaceuticals Ltd 5-hydroxymethyloxazolidin-2-onderivate
US8124623B2 (en) 2006-11-10 2012-02-28 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
US8530646B2 (en) 2007-10-02 2013-09-10 Research Foundation Itsuu Laboratory Oxazolidinone derivative having 7-membered hetero ring
JP5404652B2 (ja) * 2008-02-22 2014-02-05 アクテリオン ファーマシューティカルズ リミテッド オキサゾリジノン誘導体
CN101965353B (zh) * 2008-03-26 2014-12-17 丹诺医药(苏州)有限公司 共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
MX2011004372A (es) 2008-10-27 2011-05-23 Mitsubishi Tanabe Pharma Corp Derivado de amida novedoso y uso del mismo como medicina.
JP6030146B2 (ja) * 2011-11-08 2016-11-24 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 2−オキソ−オキサゾリジン−3,5−ジイル抗生物質誘導体
CN105246476B (zh) 2013-05-28 2019-11-15 莫弗凯姆联合化学股份公司 含噁唑烷酮-喹诺酮的联合疗法在治疗细菌感染中的应用
MX371037B (es) * 2013-05-28 2020-01-14 Morphochem Aktiengesellschaft Fuer Komb Chemie Antibacterianos híbridos de oxazolidinona-quinolona para el tratamiento parenteral o profilaxis de enfermedades bacterianas.
CN103435611B (zh) * 2013-09-07 2015-05-27 吉首大学 一类多靶点吡咯酮-喹啉酮型化合物及其制法和用途
CN103483321B (zh) * 2013-09-07 2014-08-13 吉首大学 烷基连接吡咯酮-喹啉酮型化合物及其制法和用途
CN104725330B (zh) * 2013-12-18 2017-06-13 四川好医生药业集团有限公司 噁唑烷酮类化合物及其制备方法和用途
CN107286182A (zh) * 2016-04-12 2017-10-24 李靖 新型噁唑烷酮‑氟喹诺酮衍生物及用途
CN108059624A (zh) * 2016-11-08 2018-05-22 上海医药工业研究院 用于制备咔哒唑胺关键中间体的制备方法
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid
CN112898317B (zh) * 2021-01-21 2021-12-07 河南科技大学第一附属医院 一种用于医院护理杀菌消毒的噁唑类化合物及其制备方法和应用
CN114478486B (zh) * 2022-01-28 2023-07-25 西南大学 以对氨基水杨酸为母核的三分子缀合物、中间体、制备方法及用途
TW202415651A (zh) 2022-07-29 2024-04-16 日商住友製藥股份有限公司 含氮飽和雜環衍生物

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840956A (en) 1986-02-18 1989-06-20 Warner-Lambert Company Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH0269478A (ja) 1988-09-05 1990-03-08 Sagami Chem Res Center キノロンカルボン酸誘導体
US5491139A (en) 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
EP0390215B1 (en) 1989-03-30 1995-06-07 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and salts thereof, preparation process es thereof, and antibacterial agents containing the same
IL100572A (en) 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
AU667198B2 (en) 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
US5221676A (en) 1992-02-06 1993-06-22 Warner-Lambert Company 7-substituted quinolones and naphthyridones as antibacterial agents
RU2171252C2 (ru) 1995-09-22 2001-07-27 Вакунага Фармасьютикал КО., Лтд. Аминосоединение для получения новых производных пиридонкарбоновой кислоты или их солей
DE19601265A1 (de) 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
DE19633480A1 (de) 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
WO1999037630A1 (en) 1998-01-23 1999-07-29 Versicor, Inc. Oxazolidinone combinatorial libraries, compositions and methods of preparation
TW572757B (en) 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
KR100324621B1 (ko) * 1999-04-27 2002-02-27 박호군 퀴놀론이 치환된 옥사졸리디논 유도체 및 그의 제조 방법과 항균제로서의 용도
US6441005B1 (en) 1999-07-28 2002-08-27 Pharmacia & Upjohn Company Oxazolidinone compounds and compositions, and methods of using the same
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
ATE319710T1 (de) * 2000-12-21 2006-03-15 Pharmacia & Upjohn Co Llc Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
ES2186550B2 (es) 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
WO2003031443A1 (en) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
US6624593B2 (en) 2001-10-08 2003-09-23 Randall D. Blanchard Dimmable ballast for electrodeless fluorescent lamps
US20040132764A1 (en) 2002-10-23 2004-07-08 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibiotics for the treatment of infections in acidic environments
WO2004069816A1 (en) 2003-02-07 2004-08-19 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
ES2308171T3 (es) * 2003-04-30 2008-12-01 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
AR054608A1 (es) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
KR200430712Y1 (ko) 2006-08-30 2006-11-13 명 식 신 천장등
ATE544764T1 (de) 2006-11-10 2012-02-15 Actelion Pharmaceuticals Ltd 5-hydroxymethyloxazolidin-2-onderivate
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
RU2527769C2 (ru) 2008-05-09 2014-09-10 Актелион Фармасьютиклз Лтд Производные 5-гидроксиметилоксазолидин-2-она для лечения бактериальных кишечных заболеваний

Also Published As

Publication number Publication date
DK1709044T4 (da) 2014-01-20
SI1709044T1 (sl) 2008-12-31
AU2004299278B2 (en) 2011-03-17
JP2012025748A (ja) 2012-02-09
KR101176450B1 (ko) 2012-08-30
US20120142635A1 (en) 2012-06-07
EP1709044A2 (en) 2006-10-11
US20130296275A1 (en) 2013-11-07
CY1108409T1 (el) 2014-02-12
CA2549675C (en) 2012-11-20
AU2004299278B8 (en) 2011-05-12
EP1709044B2 (en) 2013-11-20
US9133213B2 (en) 2015-09-15
JP2007516263A (ja) 2007-06-21
EP1709044B1 (en) 2008-07-16
ES2310299T5 (es) 2014-02-10
SI1709044T2 (sl) 2014-02-28
WO2005058888A2 (en) 2005-06-30
IL175409A (en) 2011-05-31
US20150336992A1 (en) 2015-11-26
CN106957316A (zh) 2017-07-18
HK1090647A1 (en) 2006-12-29
RU2371443C2 (ru) 2009-10-27
PT1709044E (pt) 2008-10-27
BRPI0417193A (pt) 2007-03-06
NZ547382A (en) 2009-11-27
IL175409A0 (en) 2006-09-05
PL1709044T5 (pl) 2014-03-31
BRPI0417193B1 (pt) 2019-01-08
CN1898238A (zh) 2007-01-17
AU2004299278A1 (en) 2005-06-30
DE602004015158D1 (de) 2008-08-28
AU2004299278C9 (en) 2013-10-24
CA2549675A1 (en) 2005-06-30
JP5722149B2 (ja) 2015-05-20
MXPA06006769A (es) 2006-12-19
US8501774B2 (en) 2013-08-06
RU2006125510A (ru) 2008-01-27
ES2310299T3 (es) 2009-01-01
BRPI0417193B8 (pt) 2021-05-25
ATE401326T1 (de) 2008-08-15
WO2005058888A3 (en) 2005-08-18
PL1709044T3 (pl) 2009-01-30
AU2004299278C1 (en) 2013-08-15
KR20070067003A (ko) 2007-06-27

Similar Documents

Publication Publication Date Title
CY1108409T1 (el) Υβριδικα αντιβιοτικα οξαζολιδινονης-κινολονης
ATE369363T1 (de) Antibiotika mit doppelwirkung
HRP20050516B1 (hr) N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
CY1108738T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου
ECSP003699A (es) Inhibidores de fab i
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
SE0000540D0 (sv) New compounds
GB0127903D0 (en) Improvements relating to organic compounds
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
IN2012DN00758A (da)
BR0313969A (pt) Inibidores de oxitocina
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ECSP066605A (es) Derivados oxazol de tetraciclina
BRPI0412446A (pt) compostos de silicio e seu uso
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
ATE374778T1 (de) Organosiliziumverbindungen und deren verwendung